Article Text

PDF
Metabolic syndrome, dysglycaemia and vascular disease: making sense of the evidence
  1. David Preiss1,
  2. Naveed Sattar2
  1. 1
    Glasgow Royal Infirmary, Scotland, UK
  2. 2
    University of Glasgow, Scotland, UK
  1. Professor N Sattar, BHF GCRC, University of Glasgow, G12 8TA, UK; nsattar{at}clinmed.gla.ac.uk

Abstract

“ ‘Diagnosis’ of metabolic syndrome by any current criteria is not needed and adds little to clinical practice. Attention and resources should be focused on the major modifiable risk factors and more should be done to engender sustainable lifestyle changes in all with vascular disease”

Statistics from Altmetric.com

Footnotes

  • Conflict of interest: None.

  • Abbreviations:
    BP
    blood pressure
    EASD
    European Association for the Study of Diabetes
    ESC
    European Society of Cardiology
    FRS
    Framingham Risk Score
    HDL
    high-density lipoprotein
    HR
    hazard ratio
    IFG
    impaired fasting glycaemia
    IDF
    International Diabetes Federation
    IGT
    impaired glucose tolerance
    LDL
    low-density lipoprotein
    NCEP
    National Cholesterol Education Panel
    OGTT
    oral glucose tolerance test

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.